PT-141, bremelanotide, and route differences
Understand why evidence for a prescription injection does not establish a benefit for a topical formula.
Read the guide
Ready-to-use PT-141 topical formula with batch documentation
A ready-to-use external cosmetic formula containing 25.5 mg of PT-141 in a 30 mL bottle. This topical format should not be assumed equivalent to research involving prescription subcutaneous bremelanotide.
25.5 mg PT-141·30 mL bottle·External cosmetic use·Batch-specific testing
Free U.S. shipping · 30-day money-back guarantee
For external cosmetic use only. Review the complete product information, ingredient list, directions, and warnings for the selected variant before use.
Full product information
See what is inside, how much is included, how the serum is formulated and applied, how it is tested, and what the available research actually means.
VitaPep PT-141 Topical Serum is a ready-to-use external cosmetic formula containing 25.5 mg of PT-141 in a 30 mL bottle. It combines a clearly disclosed peptide amount with a DMSO-based carrier, straightforward topical application, and batch-specific testing documentation.
This is a topical external-use product, not an injectable formulation. Research involving prescription subcutaneous bremelanotide should not be assumed to establish the absorption, dosing, safety profile, or effects of this serum.
| Product format | Ready-to-use topical serum |
|---|---|
| Peptide | PT-141, also known as bremelanotide |
| Listed peptide amount | 25.5 mg per 30 mL bottle |
| Measured concentration (batch PT141010) | 0.85 mg/mL |
| Listed carrier blend | 70% dimethyl sulfoxide (DMSO) and 30% deionized water |
| Testing documentation | Batch-specific concentration, purity, microbiological-quality, and heavy-metal testing |
| Intended use | Topical external cosmetic use only |
| Important distinction | Not interchangeable with a prescription injectable product |
The serum is supplied in a prepared external-use format. There is no powder to measure and no separate liquid to add.
The topical format lets you apply the amount stated in the current directions directly to the intended external area.
VitaPep identifies the peptide, bottle volume, listed concentration, carrier blend, intended use, and available testing documentation.
The PT-141 testing page identifies the submitted samples, batch, laboratories, testing scope, and reported results.
PT-141 is a development name commonly associated with bremelanotide, a synthetic cyclic peptide described as a melanocortin-receptor agonist.
The named peptide component. The current product specification lists 25.5 mg in each 30 mL bottle.
Also known as DMSO, this is listed as 70% of the formula's carrier blend.
Purified water listed as 30% of the carrier blend.
Always review the ingredient declaration on the current product packaging before use. If the packaging and online listing differ or are unclear, contact VitaPep before applying the product.
Format and route matter. The official DailyMed prescribing information for bremelanotide and published Phase III research concern a prescription subcutaneous formulation. Those sources did not evaluate this topical serum.
VitaPep PT-141 Topical Serum is a different finished product with a different application route. No controlled human study of a comparable finished topical formula was identified, so research on a subcutaneous product cannot establish equivalent absorption, safety, or effects here.
VitaPep presents this information to clarify the evidence boundary—not to imply prescription-product equivalence or a medical outcome. See the VitaPep science guide for additional context.
Each report applies to the sample and batch identified in that document. It should not be interpreted as universal testing of every bottle or as evidence of a consumer outcome.
| Laboratory document | Identified sample | Reported scope and result |
|---|---|---|
| Janoshik report 93401 | PT-141, batch PT141010 | Reported concentration of 0.85 mg/mL and peptide purity of 99.567% for the submitted sample |
| Dyad Labs certificate 1425294-1 | VitaPep PT-141 Serum, lot PT141010 | Microbiological-quality panel and arsenic, cadmium, lead, and mercury results |
Across a 30 mL product volume, 0.85 mg/mL corresponds to 25.5 mg. These reports document the submitted samples and characteristics specifically tested; they do not establish dermal absorption, clinical effectiveness, prescription-drug equivalence, or a consumer outcome.
View the PT141010 laboratory documents or learn how to read product-testing documents.
Always follow the directions supplied with the specific bottle you receive. For additional guidance, see how to read VitaPep topical serum directions.
DMSO is discussed as a penetration enhancer in pharmaceutical and research formulations, but that general property does not establish PT-141 delivery or effectiveness from this finished formula. See a peer-reviewed review of DMSO in topical formulations.
Consult a qualified healthcare professional before use if you are pregnant, breastfeeding, managing a medical condition, using prescription products, or have questions about whether the ingredients are appropriate for you. Learn more on the VitaPep standards page.
It is a ready-to-use 30 mL external cosmetic serum with a listed 25.5 mg of PT-141 in a DMSO and deionized-water carrier blend.
Published human studies involved a prescription subcutaneous formulation. VitaPep PT-141 Serum is a separate topical cosmetic product and has not been established as equivalent.
No. It is formulated and sold only for topical external cosmetic use. Do not inject or ingest it.
Route, formulation, exposure, dose, and finished-product characteristics all matter. Research involving subcutaneous prescription bremelanotide does not establish equivalent absorption, safety, or effects for this topical serum.
The current 30 mL product specification lists 25.5 mg of PT-141, corresponding to 0.85 mg/mL.
The current formula lists 70% DMSO and 30% deionized water. Review the current bottle label for the ingredient information associated with your product.
Independent laboratories evaluated identified samples for the characteristics listed in their reports. The reports should be read by batch and scope; they do not establish a biological or consumer outcome.
No. VitaPep PT-141 Serum is presented for topical external cosmetic use and should not replace diagnosis, treatment, prescription medication, or advice from a qualified healthcare professional.
Compare topical PT-141 products by the peptide amount, bottle volume, carrier ingredients, intended use, directions, warnings, and batch-specific documentation—not by claims borrowed from research on another application route.
25.5 mg PT-141 • 30 mL bottle • Ready-to-use external format • Batch-specific laboratory documentation
Shop VitaPep PT-141 Topical Serum
Explore additional formulas in the VitaPep topical serum collection or visit the VitaPep FAQ.
Continue learning
Review the molecule, the testing, and the application details before you choose a formula.
Understand why evidence for a prescription injection does not establish a benefit for a topical formula.
Read the guideUse the exact external-use instructions and applicator information supplied with your product.
Read the guideYou may also like
Compare benefits, strengths, applicators, and topical formats to find another formula that fits your routine.

Topical peptide formula

Topical peptide formula

Topical peptide formula

Topical peptide formula